Psychiatry, Psychosomatics & Psychotherapy

Research

- This section is under construction -

People

Prof. Jürgen Deckert

Director, Dept. of Psychiatry

deckert_j@ukw.de

Margarete-Höppel-Platz 1, 97080 Würzburg

+49 931 201 77000

www.ppp.ukw.de

Please reload

Publications (selected list)

Deckert J, Weber H, Villmann C, Lonsdorf TB, Richter J, Andreatta M, Arias-Vasquez A, Hommers L, Kent L, Schartner C, Cichon S, Wolf C, Schaefer N, von Collenberg CR, Wach- ter B, Blum R, Schümann D, Scharfenort R, Schumacher J, Forstner AJ, Baumann C, Schie- le MA, Notzon S, Zwanzger P, Janzing JG, Galesloot T, Kiemeney LA, Gajewska A, Glotz- bach-Schoon E, Mühlberger A, Alpers G, Fydrich T, Fehm L, Gerlach AL, Kircher T, Lang T, Ströhle A, Arolt V, Wittchen HU, Kalisch R, Büchel C, Hamm A, Nöthen MM, Romanos M, Domschke K, Pauli P, Reif A (2017). GLRB allelic variations associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder. Mol Psychiatry doi: 10.1038/mp.2017.2

 

Angermann CE, Gelbrich G, Störk S, Gunold H, Edelmann F, Wachter R, Schunkert H, Graf T, Kindermann I, Haass M, ..., Deckert J, Ertl G (2016). Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: The MOOD-HF randomized clinical trial. JAMA 315:2683–2693.

Reif A, Richter J, Straube B, Höfler M, Lueken U, Gloster AT, Weber H, Domschke K, Fehm L, Ströhle A, ..., Deckert J (2014). MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. Mol Psychiatry 19:122–128.

Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Sus- low T, Kugel H, ..., Deckert J (2011). Neuropeptide S receptor gene - converging evidence for a role in panic disorder. Mol Psychiatry 16:938–948.

Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, Specht M, Kohli MA, Kloi- ber S, Ising M, ..., Deckert J et al (2011). TMEM132D, a new candidate for anxiety pheno- types: evidence from human and mouse studies. Mol Psychiatry 16:647–663.

Alsene K, Deckert J, Sand PG, de Wit H (2003). Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28:1694–1702.

Deckert J, Catalano M, Syagailo J, Bosi M, Okladnova O, DiBella D, Nöthen MM, Maffei P, Franke P, Fritze J et al (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621–624.

Deckert J, Nöthen MM, Franke P, Delmo C, Fritze J, Knapp M, Maier W, Beckmann H, Propping P (1998). Systematic mutation screening and association study of the A1 and A2A adenosine receptor genes in panic disorder suggest a contribution of the A2A gene to the development of disease. Mol Psychiatry 3:81–85.

Deckert J, Bisserbe JC, Klein E, Marangos PJ (1988). Adenosine uptake sites in brain: Dis- tribution of putative subtypes in relationship to adenosine A1 receptors. J Neurosci 8:2338– 2349.

Weber H, Richter J, Straube B, Lueken U, Domschke K, Schartner C, Klauke B, Baumann C, Pané-Farré C, Jacob CP, ..., Deckert J, Reif A (2016). Allelic variation in CRHR1 predispos- es to panic disorder: evidence for biased fear processing. Mol Psychiatry 21:813–822. 

© 2019 by Philip Tovote

  • Grey Facebook Icon
  • Grey Twitter Icon

last update: 10/29/2019